Ningbo Menovo Pharmaceutical Co.,Ltd.’s Net Profit Dropped 63.6% in First Quarter of 2023

Ningbo Menovo Pharmaceutical Co.,Ltd. (宁波美诺华药业股份有限公司) (603538.SH) reported a net profit of 46.2 million yuan in the first quarter of 2023, down 63.6% year-on-year.

Meanwhile, the company posted 246.3 million yuan in revenue, down 50.8% year-on-year.

At the end of the reporting period, it had 4.4 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 49.7%.